These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36343257)

  • 1. Aβ and tau prions feature in the neuropathogenesis of Down syndrome.
    Condello C; Maxwell AM; Castillo E; Aoyagi A; Graff C; Ingelsson M; Lannfelt L; Bird TD; Keene CD; Seeley WW; Perl DP; Head E; Prusiner SB
    Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2212954119. PubMed ID: 36343257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ and Tau Prions Causing Alzheimer's Disease.
    Condello C; Merz GE; Aoyagi A; DeGrado WF; Prusiner SB
    Methods Mol Biol; 2023; 2561():293-337. PubMed ID: 36399277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guam ALS-PDC is a distinct double-prion disorder featuring both tau and Aβ prions.
    Condello C; Ayers JI; Dalgard CL; Garcia Garcia MM; Rivera BM; Seeley WW; Perl DP; Prusiner SB
    Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2220984120. PubMed ID: 36952379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.
    Aoyagi A; Condello C; Stöhr J; Yue W; Rivera BM; Lee JC; Woerman AL; Halliday G; van Duinen S; Ingelsson M; Lannfelt L; Graff C; Bird TD; Keene CD; Seeley WW; DeGrado WF; Prusiner SB
    Sci Transl Med; 2019 May; 11(490):. PubMed ID: 31043574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryo-EM structures of amyloid-β and tau filaments in Down syndrome.
    Fernandez A; Hoq MR; Hallinan GI; Li D; Bharath SR; Vago FS; Zhang X; Ozcan KA; Newell KL; Garringer HJ; Jiang W; Ghetti B; Vidal R
    Nat Struct Mol Biol; 2024 Jun; 31(6):903-909. PubMed ID: 38553642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage.
    Whitehouse IJ; Miners JS; Glennon EB; Kehoe PG; Love S; Kellett KA; Hooper NM
    PLoS One; 2013; 8(4):e59554. PubMed ID: 23577068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold.
    Ghosh U; Tse E; Yang H; Shi M; Caro CD; Wang F; Merz GE; Prusiner SB; Southworth DR; Condello C
    Acta Neuropathol Commun; 2024 Jun; 12(1):94. PubMed ID: 38867338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric-Aβ mediates pathology maturation.
    Darricau M; Dou C; Kinet R; Zhu T; Zhou L; Li X; Bedel A; Claverol S; Tokarski C; Katsinelos T; McEwan WA; Zhang L; Gao R; Bourdenx M; Dehay B; Qin C; Bezard E; Planche V
    Alzheimers Dement; 2024 Mar; 20(3):1894-1912. PubMed ID: 38148705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome.
    Ichimata S; Martinez-Valbuena I; Lee S; Li J; Karakani AM; Kovacs GG
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.
    Vergara C; Ordóñez-Gutiérrez L; Wandosell F; Ferrer I; del Río JA; Gavín R
    Mol Neurobiol; 2015; 51(3):1206-20. PubMed ID: 24965601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer disease: a tale of two prions.
    Nussbaum JM; Seward ME; Bloom GS
    Prion; 2013; 7(1):14-9. PubMed ID: 22965142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers.
    Janelidze S; Christian BT; Price J; Laymon C; Schupf N; Klunk WE; Lott I; Silverman W; Rosas HD; Zaman S; Mapstone M; Lai F; Ances BM; Handen BL; Hansson O
    JAMA Neurol; 2022 Aug; 79(8):797-807. PubMed ID: 35789365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.
    Mengel D; Liu W; Glynn RJ; Selkoe DJ; Strydom A; Lai F; Rosas HD; Torres A; Patsiogiannis V; Skotko B; Walsh DM
    Alzheimers Res Ther; 2020 Mar; 12(1):27. PubMed ID: 32192521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
    Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
    Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
    Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
    PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
    Lemoine L; Ledreux A; Mufson EJ; Perez SE; Simic G; Doran E; Lott I; Carroll S; Bharani K; Thomas S; Gilmore A; Hamlett ED; Nordberg A; Granholm AC
    Mol Neurodegener; 2020 Nov; 15(1):68. PubMed ID: 33222700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.